A View LCS vs cvi42 Auto Imaging

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

A View LCS

by Coreline Soft

cvi42 Auto Imaging

by Circle Cardiovascular Imaging Inc.

AI Verdict

Tool A (A View LCS) is designed for comprehensive thoracic CT analysis, including lung cancer screening and emphysema quantification, alongside coronary artery calcification detection. Tool B (cvi42 Auto Imaging) specializes in cardiovascular MR and CT analysis, offering advanced cardiac MR capabilities and detailed plaque assessment. Therefore, while both provide coronary artery assessment from CT, Tool A is more suitable for pulmonary and oncology screening, whereas Tool B excels in detailed cardiovascular MR and advanced plaque characterization.

Choose A View LCS if…

Choose A View LCS if your primary need is a comprehensive, AI-powered platform for thoracic CT analysis, particularly for lung cancer screening programs. It excels at detecting and quantifying lung nodules, assessing emphysema, and performing coronary artery calcification scoring from a single low-dose CT scan, streamlining multi-disease screening workflows.

View A View LCS →

Choose cvi42 Auto Imaging if…

Choose cvi42 Auto Imaging if your focus is on advanced, multi-modality cardiovascular imaging analysis, including both MR and CT. This tool is ideal for detailed cardiac function assessment (e.g., strain analysis from MR), comprehensive coronary artery evaluation, and precise plaque quantification, offering in-depth insights for complex cardiovascular diagnoses and treatment planning.

View cvi42 Auto Imaging →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	A View LCS	cvi42 Auto Imaging
Pricing	Unknown	Starts at $5000 per license
Deployment	Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application.	On-premise (standalone workstation or client/server)
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

A View LCS

Tool A offers a wider range of deployment options, including cloud, hybrid, and virtualized solutions, which can enhance flexibility and ease of integration into various IT environments. Its 'CT kernel conversion AI technology' also suggests an ability to standardize inputs, potentially simplifying workflow for users across different scanner types.

Clinical Value

cvi42 Auto Imaging

While both tools are FDA-cleared and offer comprehensive analysis, Tool B provides a broader and deeper set of analyses within the cardiovascular domain, including advanced cardiac MR features like Function, Flow, Tissue Characterization, and Strain. Its multi-modality support (MR, CT) and detailed plaque assessment offer more extensive diagnostic capabilities for cardiovascular conditions.

Pricing & Value

Tie

Both tools require direct contact for pricing information, making a direct comparison of their value propositions difficult without specific quotes. Tool B explicitly mentions modular licensing and additional costs for specific features, which could lead to a more complex pricing structure, but without concrete numbers, neither demonstrates superior pricing transparency or value.

Enterprise Readiness

A View LCS

Tool A explicitly states it is HIPAA compliant and provides a Business Associate Agreement (BAA), which are crucial for enterprise adoption in healthcare. Its comprehensive deployment options, including cloud and hybrid, further enhance its readiness for diverse enterprise IT infrastructures.

Innovation

cvi42 Auto Imaging

Tool B demonstrates a higher degree of innovation through its multi-modality support (MR and CT) and advanced cardiac MR analysis capabilities, such as Strain and Tissue Characterization. These features address complex diagnostic challenges and represent sophisticated AI application in diverse imaging data.

Support & Docs

Tie

Neither the provided structured facts nor publicly available web searches offer specific details regarding the quality, depth, or accessibility of support and documentation for either tool. Without this information, it is not possible to distinguish between the two products in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	A View LCS	cvi42 Auto Imaging
Name	A View LCS	cvi42 Auto Imaging
Company	Coreline Soft Co.	Circle Cardiovascular Imaging
Primary Focus	Comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan.	Comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows.
Categories	Cardiology AI, Oncology AI, Radiology & Imaging AI	Cardiology AI, Radiology & Imaging AI
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Radiology, Vascular Surgery

Videos

Demos, reviews, and walkthroughs featuring A View LCS and cvi42 Auto Imaging.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What imaging modalities and anatomical areas do these tools primarily support?

AVIEW LCS by Coreline Soft focuses on comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification from a single low-dose CT scan. cvi42 Auto Imaging by Circle Cardiovascular Imaging is designed for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows, including cardiac and vascular assessments.

How do the cardiac analysis capabilities differ, especially concerning MR imaging and plaque assessment?

AVIEW LCS offers Coronary Artery Calcium (CAC) scoring using Agatston, volume, and mass, along with segmentation of major coronary arteries from CT scans. cvi42 Auto Imaging provides extensive cardiac MR analysis (Function, Flow, Tissue Characterization, Strain) and cardiac CT analysis, including detailed plaque assessment (calcified, non-calcified, low-density) and CAD-RADS classification.

Which tool is better suited for detailed lung pathology analysis, such as nodule detection and emphysema quantification?

AVIEW LCS specializes in automated lung nodule detection, classification, and volume quantification, Lung-RADS scoring and reporting, and emphysema analysis and quantification. cvi42 Auto Imaging does not list specific features for lung nodule or emphysema analysis.

What types of reporting and classification systems are integrated into each software?

AVIEW LCS generates automated comprehensive reports in PDF, DICOM PDF, and SR formats, and supports Lung-RADS scoring and reporting. cvi42 Auto Imaging offers simplified and smart reporting with infographics and CAD-RADS classification, and supports standard integrated reports with customizable templates.

Beyond cardiac analysis, what other vascular applications does each tool support?

AVIEW LCS focuses on thoracic CT analysis and does not list specific broader vascular applications beyond coronary artery analysis. cvi42 Auto Imaging includes vascular CT analysis for diagnosis, planning, and surveillance, and has expanded its platform to include advanced vascular analysis.